In agreement with previous reports, the addition of anti-CSF-1R to anti-PD-L1 + anti-TIGIT partially depleted macrophages from the tumour beds of treated mice (Extended Data Fig. 9a) and sustained tumour responsiveness to checkpoint inhibitors (Extended Data Fig. 9b). This evidence concerns the gene TIGIT and neoplasm.